Minerva Neurosciences regains Nasdaq compliance on minimum market value requirement

Minerva Neurosciences, Inc.

Received Nasdaq Compliance Notice on June 16, 2023, after MVLS exceeded $35M for 10 consecutive business days.
Previously faced delisting due to non-compliance; hearing before Nasdaq Hearings Panel cancelled.
Company's common stock will continue trading on Nasdaq Capital Market.
Regained compliance resolves listing uncertainty.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.